Chris Wagner

Chris Wagner

Amministratore Delegato presso
Immunoflex Therapeutics, Inc.
57 anni
Health Technology
Consumer Services
Industrial Services

Profilo

Chris Wagner was the founder of Canexia Health, Inc. (Canada), founded in 2012, where the title held was Chief Executive Officer.
Mr. Wagner is also the founder of Aspreva Pharmaceuticals Corp.,Immunoflex Therapeutics, Inc...
Mr. Wagner currently holds the position of Director at Contextual Health since 2019.
Mr. Wagner also serves as Area Manager-New Mexico at Meridian Engineering Co. Former positions include President & Chief Executive Officer at Sirius Genomics, Inc., Director at Emerald Health Therapeutics, Inc. from 2018 to 2019, Independent Director at Filament Health Corp.
from 2021 to 2024, and Principal at Eli Lilly & Co. Education includes undergraduate studies at the University of British Columbia.

Posizioni attive di Chris Wagner

SocietàPosizioneInizio
Direttore/Membro del Consiglio 01/05/2019
Corporate Officer/Principal -
Immunoflex Therapeutics, Inc.
Amministratore Delegato -

Precedenti posizioni note di Chris Wagner

SocietàPosizioneFine
FILAMENT HEALTH CORP. Direttore/Membro del Consiglio 01/04/2024
EMERALD HEALTH THERAPEUTICS Amministratore Delegato 28/11/2018
Amministratore Delegato -
Fondatore -
ELI LILLY AND COMPANY Corporate Officer/Principal -
Vedi nel dettaglio l'esperienza di Chris Wagner

Formazione di Chris Wagner

Esperienze
Posizioni ricoperte

Attive

Inattive

Società nel listino

Aziende private

Relazioni

8

Relazioni di 1° grado

10

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Società collegate

Aziende private10

Health Technology

Health Technology

Consumer Services

Health Technology

Industrial Services

Process Industries

Health Technology

Health Technology

Immunoflex Therapeutics, Inc.

Health Services

  1. Mercati
  2. Insiders
  3. Chris Wagner